Related Experiment Videos
Recurrent histiocytosis X with mandibular lesions
Oral Surgery, Oral Medicine, and Oral Pathology
|October 1, 1984
Summary
Recurrence of histiocytosis X in a 19-year-old male manifested as mandibular bone lesions and dental issues. Treatment with low-dose radiation and oral chemotherapy led to lesion regression, highlighting effective management strategies.
Area of Science:
- Oncology
- Pediatric Oncology
- Dermatology
Background:
- Histiocytosis X, now known as Langerhans cell histiocytosis (LCH), is a rare clonal proliferative disorder of Langerhans cells.
- LCH can affect multiple organ systems, including bone, skin, lymph nodes, and the central nervous system.
- Recurrence of LCH after a period of remission is a recognized clinical challenge.
Observation:
- A 19-year-old male presented with recurrent histiocytosis X 11 years after initial remission.
- Radiographic examination revealed bony lesions in the mandible.
- Clinical symptoms included loose and painful teeth, indicative of oral involvement.
Findings:
- The patient received low-dose radiation therapy directed at the mandibular lesions.
- Oral chemotherapy was administered as part of the treatment regimen.
- Both treatment modalities contributed to the regression of the bony lesions.
Implications:
- This case highlights the possibility of late recurrence of histiocytosis X, even after prolonged remission.
- Combined modality treatment, including radiation and chemotherapy, can be effective in managing recurrent mandibular LCH.
- Further review of incidence, treatment options, and recurrence patterns is warranted for optimizing patient care.